Clinical significance of alpha2H-globulin.
Incidences of alpha2H were investigated in sera from patients with various malignant and nonmalignant diseases. With counterimmunoelectrophoresis, alpha2H was detected in a wide variety of neoplastic diseases, and also in nonmalignant hematological disorders. Diagnostic significance was described regarding primary hepatoma and acute myelogenous leukemia. Factors affecting alpha2H levels in sera were also discussed in relation to the neoplastic and nonneoplastic disease process.
D000510:Alpha-Globulins / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000032:analysis* / Q000276:immunology; D005260:Female; D005333:Fetus; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008099:Liver / Q000032:analysis* / Q000196:embryology / Q000473:pathology; D008113:Liver Neoplasms; D008667:Metalloproteins / Q000097:blood; D009101:Multiple Myeloma / Q000097:blood* / Q000276:immunology; D009369:Neoplasms / Q000097:blood; D011247:Pregnancy; D000509:alpha-Fetoproteins / Q000032:analysis
D000510:Alpha-Globulins; D001798:Blood Proteins; D008667:Metalloproteins; D000509:alpha-Fetoproteins